Annual CFF
$2.72 M
-$16.65 M-85.96%
December 31, 2021
Summary
- As of February 10, 2025, OPNT annual cash flow from financing activities is $2.72 million, with the most recent change of -$16.65 million (-85.96%) on December 31, 2021.
- During the last 3 years, OPNT annual CFF has fallen by -$14.30 million (-84.03%).
Performance
OPNT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$402.60 K
+$266.90 K+196.68%
September 30, 2022
Summary
- As of February 10, 2025, OPNT quarterly cash flow from financing activities is $402.60 thousand, with the most recent change of +$266.90 thousand (+196.68%) on September 30, 2022.
- Over the past year, OPNT quarterly CFF has dropped by -$1.14 million (-73.96%).
Performance
OPNT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$1.19 M
-$1.14 M-48.94%
September 30, 2022
Summary
- As of February 10, 2025, OPNT TTM cash flow from financing activities is $1.19 million, with the most recent change of -$1.14 million (-48.94%) on September 30, 2022.
- Over the past year, OPNT TTM CFF has dropped by -$19.65 million (-94.28%).
Performance
OPNT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
OPNT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -86.0% | -74.0% | -94.3% |
| 3 y3 years | -84.0% | +49.1% | -54.2% |
| 5 y5 years | -46.5% | - | -54.2% |
OPNT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -27.7% | -75.8% | -56.1% | at low |
| 5 y | 5-year | -86.0% | -4.2% | -97.8% | -100.0% | -94.3% | at low |
| alltime | all time | -86.0% | -106.1% | -97.8% | -141.0% | -94.3% | -113.8% |
Opiant Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $402.60 K(+196.7%) | $1.19 M(-48.9%) |
| Jun 2022 | - | $135.70 K(+39.2%) | $2.34 M(+4.4%) |
| Mar 2022 | - | $97.50 K(-82.5%) | $2.24 M(-17.7%) |
| Dec 2021 | $2.72 M(-86.0%) | $556.90 K(-64.0%) | $2.72 M(-87.0%) |
| Sep 2021 | - | $1.55 M(+4123.5%) | $20.85 M(+8.0%) |
| Jun 2021 | - | $36.60 K(-93.7%) | $19.30 M(+0.2%) |
| Mar 2021 | - | $579.60 K(-96.9%) | $19.26 M(-0.5%) |
| Dec 2020 | $19.37 M(+643.4%) | $18.68 M(>+9900.0%) | $19.37 M(+1121.7%) |
| Sep 2020 | - | $0.00(0.0%) | $1.59 M(-14.6%) |
| Jun 2020 | - | $0.00(-100.0%) | $1.86 M(-31.0%) |
| Mar 2020 | - | $685.10 K(-23.9%) | $2.69 M(+3.2%) |
| Dec 2019 | $2.61 M(-84.7%) | $900.30 K(+233.4%) | $2.61 M(+52.2%) |
| Sep 2019 | - | $270.00 K(-67.6%) | $1.71 M(-89.3%) |
| Jun 2019 | - | $833.90 K(+38.7%) | $16.00 M(-3.5%) |
| Mar 2019 | - | $601.20 K(+8873.1%) | $16.59 M(-2.5%) |
| Dec 2018 | $17.02 M(+234.8%) | $6700.00(-100.0%) | $17.02 M(+0.0%) |
| Sep 2018 | - | $14.56 M(+924.8%) | $17.01 M(+594.2%) |
| Jun 2018 | - | $1.42 M(+38.0%) | $2.45 M(+138.0%) |
| Mar 2018 | - | $1.03 M(>+9900.0%) | $1.03 M(-724.2%) |
| Dec 2017 | $5.08 M(-3181.1%) | - | - |
| Jul 2017 | -$165.00 K(-108.4%) | $0.00(0.0%) | -$165.00 K(-127.4%) |
| Apr 2017 | - | $0.00(-100.0%) | $601.50 K(0.0%) |
| Jan 2017 | - | -$165.00 K(-121.5%) | $601.50 K(-69.5%) |
| Jul 2016 | $1.97 M(-55.4%) | $766.50 K(>+9900.0%) | $1.97 M(+35.5%) |
| Apr 2016 | - | $0.00(-100.0%) | $1.45 M(-40.5%) |
| Jan 2016 | - | $434.30 K(-43.5%) | $2.44 M(-26.5%) |
| Oct 2015 | - | $769.20 K(+207.7%) | $3.32 M(-24.8%) |
| Jul 2015 | $4.42 M | $250.00 K(-74.7%) | $4.42 M(-3.5%) |
| Apr 2015 | - | $988.00 K(-24.8%) | $4.58 M(+27.5%) |
| Jan 2015 | - | $1.31 M(-29.6%) | $3.59 M(+41.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2014 | - | $1.87 M(+357.6%) | $2.53 M(+282.2%) |
| Jul 2014 | $661.50 K(-50.1%) | $408.00 K(>+9900.0%) | $661.50 K(+95.2%) |
| Apr 2014 | - | $0.00(-100.0%) | $338.80 K(-68.5%) |
| Jan 2014 | - | $253.50 K(>+9900.0%) | $1.07 M(-5.6%) |
| Oct 2013 | - | $0.00(-100.0%) | $1.14 M(-14.1%) |
| Jul 2013 | $1.33 M(+24.4%) | $85.30 K(-88.4%) | $1.33 M(-16.4%) |
| Apr 2013 | - | $736.00 K(+132.4%) | $1.58 M(+58.7%) |
| Jan 2013 | - | $316.70 K(+68.9%) | $998.60 K(+29.8%) |
| Oct 2012 | - | $187.50 K(-45.6%) | $769.10 K(-27.8%) |
| Jul 2012 | $1.07 M(-64.6%) | $344.40 K(+129.6%) | $1.07 M(+44.8%) |
| Apr 2012 | - | $150.00 K(+72.0%) | $735.70 K(-75.9%) |
| Jan 2012 | - | $87.20 K(-82.0%) | $3.06 M(-7.3%) |
| Oct 2011 | - | $483.70 K(+3168.2%) | $3.30 M(+9.7%) |
| Jul 2011 | $3.01 M(+689.6%) | $14.80 K(-99.4%) | $3.01 M(-1.1%) |
| Apr 2011 | - | $2.47 M(+651.9%) | $3.04 M(+312.9%) |
| Jan 2011 | - | $328.50 K(+71.1%) | $735.70 K(+28.5%) |
| Oct 2010 | - | $192.00 K(+307.6%) | $572.60 K(+50.4%) |
| Jul 2010 | $380.60 K(>+9900.0%) | $47.10 K(-72.0%) | $380.60 K(+14.1%) |
| Apr 2010 | - | $168.10 K(+1.6%) | $333.50 K(+101.6%) |
| Jan 2010 | - | $165.40 K(>+9900.0%) | $165.40 K(>+9900.0%) |
| Oct 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jul 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Apr 2009 | - | $0.00(0.0%) | -$10.60 K(+10.4%) |
| Jan 2009 | - | $0.00(0.0%) | -$9600.00(<-9900.0%) |
| Oct 2008 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Jul 2008 | $0.00 | -$10.60 K(-1160.0%) | $0.00(-100.0%) |
| Apr 2008 | - | $1000.00(-89.6%) | $10.60 K(+10.4%) |
| Jan 2008 | - | $9600.00(>+9900.0%) | $9600.00(>+9900.0%) |
| Oct 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2006 | - | $0.00 | $0.00 |
FAQ
- What is Opiant Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual CFF year-on-year change?
- What is Opiant Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly CFF year-on-year change?
- What is Opiant Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals TTM CFF year-on-year change?
What is Opiant Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of OPNT is $2.72 M
What is the all time high annual CFF for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual cash flow from financing activities is $19.37 M
What is Opiant Pharmaceuticals annual CFF year-on-year change?
Over the past year, OPNT annual cash flow from financing activities has changed by -$16.65 M (-85.96%)
What is Opiant Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of OPNT is $402.60 K
What is the all time high quarterly CFF for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly cash flow from financing activities is $18.68 M
What is Opiant Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, OPNT quarterly cash flow from financing activities has changed by -$1.14 M (-73.96%)
What is Opiant Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of OPNT is $1.19 M
What is the all time high TTM CFF for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high TTM cash flow from financing activities is $20.85 M
What is Opiant Pharmaceuticals TTM CFF year-on-year change?
Over the past year, OPNT TTM cash flow from financing activities has changed by -$19.65 M (-94.28%)